FindTrial
Sign In

A diagnostic performance of Narrow Band Imaging followed by Lugol’s Chromoendoscopy combined with Probe-based Confocal Laser Endomicroscopy for Early Esophageal Squamous Cell Neoplasm in Patient with Head and Neck Cancers.

A diagnostic performance of Narrow Band Imaging followed by Lugol’s Chromoendoscopy combined with Probe-based Confocal Laser Endomicroscopy for Early Esophageal Squamous Cell Neoplasm in Patient with Head and Neck Cancers.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180223004
Enrollment
Unknown
Registered
2018-02-23
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with head and neck squamous cell carcinoma (SCC) had the highest risk of developing second primary esophageal SCC. Lugol’s chromoendoscopy (LCE) was the gold standard for esophageal squamou Narrow Band Imaging&#44

Interventions

Patient with Head and Neck Squamous cell carcinoma (except nasophalyngeal carcinoma)
Diagnostic
Patient with Head and Neck Cancers

Sponsors

Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Lead Sponsor
Ratchadapiseksompotch Fund&#44
Collaborator
Faculty of Medicine&#44
Collaborator
Chulalongkorn University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were age older than 18 and no dysphagia symptom.

Exclusion criteria

Exclusion criteria: The exclusion criteria were a history of nasopharyngeal squamous cell carcinoma esophageal surgery, esophageal stricture or obstruction, esophageal varices, known cases of esophageal cancer, uncorrectable coagulopathy and thrombocytopenia, pregnancy, thyrotoxicosis, creatinine clearance less than 30 mL/min, and a history of allergy to iodine and fluorescein.

Design outcomes

Primary

MeasureTime frame
performance of dNBI for second primary ESCN diagnosis in patients with head and neck cancer at diagnosis esophagogastroduodenoscopy—

Secondary

MeasureTime frame
performance of LCE and pCLE for second primary ESCN diagnosis in patients with head and neck cancer at diagnosis esophagogastroduodenoscopy—

Countries

Thailand

Contacts

Public ContactThanawat Luangsukrerk

King Chulalongkorn Memoral hospital

drthanawatl@gmail.com0896607466

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026